KJ Tower
8th Floor 207 Bongeunsa-ro Nonhyeon-dong, Gangnam-gu
Seoul
South Korea
82 2 2106 5417
https://su-holdings.com
Sektor(en):
Branche:
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Moon-Wui Chung | Chief Executive Officer and President | N/A | N/A | 1971 |
SU-Holdings Co.,Ltd., a medical company, develops and sells brain disease treatment devices based on image guided low intensity focused ultrasound technology in the brain neuromodulation market. Its product is NEUROSONA, a treatment device for brain disease. The company was formerly known as NSN Co., Ltd. and changed its name to SU-Holdings Co.,Ltd. in July 2023. SU-Holdings Co.,Ltd. was founded in 1979 and is based in Seoul, South Korea.
SU-Holdings Co.,Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.